SPY458.97-10.47 -2.23%
DIA349.02-9.01 -2.52%
IXIC15,491.66-353.57 -2.23%

BRIEF-Oncorus Announces Exclusive Licensing Agreement With Gaeta Therapeutics Ltd

reuters.com · 11/11/2021 07:01
BRIEF-Oncorus Announces Exclusive Licensing Agreement With Gaeta Therapeutics Ltd

- Oncorus Inc ONCR:

  • ONCORUS ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH GAETA THERAPEUTICS LTD. FOR USE OF LOCALLY DELIVERED INTERLEUKIN-12 (IL-12) VIA ONCOLYTIC VIRAL EXPRESSION IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

  • ONCORUS INC - GAETA WILL RECEIVE PAYMENT OF $0.2M AND IS ELIGIBLE TO RECEIVE UP TO $7.5M IN POTENTIAL CLINICAL AND REGULATORY MILESTONE PAYMENTS

Source text for Eikon: ID:nGNXbLlCFC

Further company coverage: ONCR


((Reuters.Briefs@thomsonreuters.com;;))